Eric Howard | Research Excellence | Research Excellence Award

Published on by Scientist Day

Dr. Eric Howard | Research Excellence | Research Excellence Award

Dr. Eric Howard | Macquarie University | Australia

Dr. Eric Howard is an accomplished academic leader, researcher, and innovator with nearly three decades of combined experience across computational physics, astronomy, quantum computing, data science, and cybersecurity. He has made influential contributions through teaching, curriculum design, research supervision, and interdisciplinary program development across multiple higher-education sectors. His academic leadership includes directing programs and advancing pedagogical frameworks for undergraduate, postgraduate, and MBA-level studies. Dr. Howard’s research portfolio reflects significant advancements in emerging technologies. His completed and ongoing projects span quantum machine learning for fraud detection, hybrid quantum-classical neural networks for intrusion detection, quantum Bayesian inference models, variational simulations of molecular ground states, holographic beam shaping with AI optimization, and quantum graph neural networks for complex systems. He has published more than sixty peer-reviewed papers in respected SCI and Scopus-indexed journals, covering quantum information science, artificial intelligence, cosmology, cryptography, and computational physics. He also contributes to global scholarship as an editor for international journals in physics and theoretical mathematics, while serving as a peer reviewer for prominent scientific publishers and organizations. In addition, Dr. Howard maintains strong collaborative ties with national research institutes, quantum technology networks, and centers of excellence, advancing high-impact interdisciplinary projects. In industry, Dr. Howard has demonstrated entrepreneurial leadership as CEO of companies specializing in AI-powered cybersecurity and data-driven digital automation. His consultancy experience includes developing secure e-learning ecosystems, threat intelligence platforms, cloud security frameworks, and advanced analytics solutions for enterprise and academic clients. Dr. Howard’s key contributions include pioneering quantum-enhanced cybersecurity models, designing AI-driven threat intelligence frameworks, and leading competitive grant-funded projects in quantum sensing, VQE simulations, and digital security. His sustained commitment to innovation, mentorship, and research excellence underscores his significant impact on scientific, technological, and educational advancement.

Profile: Orcid | Google Scholar

Featured Publications

Howard, E. (2025). Data imputation with deep learning: AI techniques for handling missing or noisy data. Eksplorium. https://doi.org/10.52783/eksplorium.65

Howard, E. (2025). End-to-end visibility in global supply chains: Blockchain and AI integration [Dataset]. figshare. https://doi.org/10.6084/m9.figshare.28528676

Howard, E. (2025). Leveraging computer vision and data science for enhanced operational efficiency in smart enterprises. Tangence. https://doi.org/10.52783/tangence.6

Ramshankar, P., Howard, E., Srinivasan, V., Prabu, D., Dhanraj, J. A., Kumar, M. J., & Rajendiran, M. (2025). Nanoscale characterization and imaging techniques for material analysis. AIP Conference Proceedings. https://doi.org/10.1063/5.0277578

Howard, E. (2025). Optimization of heat transfer in mechanical systems using AI in neural networks. Tangence. https://doi.org/10.52783/tangence.3

Howard, E. (2025). Real-time image-based data processing and its applications in managerial decision-making and risk analysis. Eksplorium. https://doi.org/10.52783/eksplorium.181

Jyoti Srivastava | Research Excellence | Best Researcher Award

Published on by Scientist Day

Dr. Jyoti Srivastava | Research Excellence | Best Researcher Award

Dr. Jyoti Srivastava | Moffitt Cancer Center | United States

Dr. Jyoti Srivastava, Senior Research Scientist in the Department of Tumor Microenvironment and Metastasis at Moffitt Cancer Center, is an accomplished molecular biologist with over 18 years of pioneering experience spanning cancer biology, immuno-oncology, and therapeutic discovery. Her multidisciplinary research integrates molecular genetics, pharmacology, redox biology, and genomics to uncover mechanisms driving tumor progression, metastasis, and drug resistance. At Moffitt, Dr. Srivastava has made groundbreaking discoveries in melanoma, elucidating how redox and nitrosylation signaling pathways modulate immune evasion and therapeutic resistance in NRAS-driven cancers. Her work has identified actionable targets and led to the development of innovative RNAi-, PROTAC-, and small-molecule–based therapeutics that have advanced toward preclinical and clinical evaluation. Previously at Arrowhead Pharmaceuticals and Yale University, she spearheaded translational research programs that delivered clinical candidates for lung diseases and cancer, while uncovering novel oncogenic pathways such as AEG-1/MTDH in hepatocellular carcinoma and non-alcoholic steatohepatitis (NASH). Dr. Srivastava’s contributions—reflected in over 30 peer-reviewed publications, invited talks at major international conferences, and successful therapeutic innovations—underscore her leadership in bridging fundamental discoveries with clinical application, advancing next-generation strategies to combat cancer and chronic diseases.

Profiles: Google Scholar

Featured Publications 

Yoo, B. K., Santhekadur, P. K., Gredler, R., Chen, D., Emdad, L., Bhutia, S., … & Fisher, P. B. (2011). Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology, 53(5), 1538–1548. https://doi.org/10.1002/hep.24221

Santhekadur, P. K., Das, S. K., Gredler, R., Chen, D., Srivastava, J., Robertson, C., … & Fisher, P. B. (2012). Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through a novel pathway involving NF-κB and miR-221. Journal of Biological Chemistry, 287(17), 13952–13958. https://doi.org/10.1074/jbc.M111.323899

Sarkar, D., & Fisher, P. B. (2013). AEG-1/MTDH/Lyric: Clinical significance. Advances in Cancer Research, 120, 39–74. https://doi.org/10.1016/B978-0-12-401676-7.00002-0

Srivastava, J., Siddiq, A., Emdad, L., Santhekadur, P. K., Chen, D., Gredler, R., … & Fisher, P. B. (2012). Astrocyte elevated gene-1 promotes hepatocarcinogenesis: Novel insights from a mouse model. Hepatology, 56(5), 1782–1791. https://doi.org/10.1002/hep.25841

Santhekadur, P. K., Akiel, M., Emdad, L., Gredler, R., Srivastava, J., … & Fisher, P. B. (2014). Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGF-β signaling. FEBS Open Bio, 4, 353–361. https://doi.org/10.1016/j.fob.2014.03.001